NOP hematologic next generation sequencing testing for the richard L roudebush VA medical center
Ended Awarded Last action
- Contract number
- 36C25020F0903
- Awardee
-
Foundation Medicine, Inc. UEI EHXPZ92G4AD1
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $135,529
Award facts
- Opportunity
-
- Genomic Sequencing Services Pre-Solicitation · Posted Aug 8, 2018
- Contract value 100% obligated
- $135,528.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- East Cambridge, MA 02141, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$278,876 | |
| Exercise an Option | $130,316 | |
| Exercise an Option | $130,316 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $70,371 | |
| Supplemental Agreement for work within scope | $39,095 | |
| Supplemental Agreement for work within scope | $10,425 | |
| Exercise an Option | $20,851 | |
| Original award | $13,032 |
About this award
This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services. The contract, valued at $135,528.64, is for Next Generation Sequencing (NGS) testing services to support the VA's National Precision Oncology Program at the Richard L. Roudebush VA Medical Center.
The contract is a Firm Fixed Price Delivery Order issued under a larger Indefinite Delivery Contract (IDC) worth $130.7 million that Foundation Medicine holds with the VA. This IDC, awarded in September 2024, is for specialized comprehensive reference laboratory-based tumor molecular profiling services to support the VA's precision oncology initiatives nationwide. The contract does not have a set-aside designation, reflecting the specialized nature of the genomic testing services provided by Foundation Medicine. Under this contract, the company is required to analyze a minimum of 5,000 tumor samples annually and provide associated genomic reports to aid in clinical decision-making for oncology patients at VA medical centers.
Quick answers
Who was awarded contract 36C25020F0903?
36C25020F0903 was awarded to Foundation Medicine, Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on July 15, 2020.
How much is contract 36C25020F0903 worth?
The government has obligated $135,529 on 36C25020F0903.
Is contract 36C25020F0903 an order under another contract?
Yes. 36C25020F0903 is a delivery order under 36C10G19D0032, an indefinite delivery contract.
Was contract 36C25020F0903 competed?
The extent of competition for 36C25020F0903 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award